Aurora Cannabis Operating Income 2011-2026 | ACB

Operating profit (also called operating income or profit from core activities) is a financial metric that reflects a company's profit from its main operational activities before interest expenses and taxes are taken into account.

Formula

Operating profit = Revenue – Operating expenses

Features of the metric

Evaluates business efficiency
Shows how well the company controls its production and administrative costs.
Independent of financial structure
Excludes the impact of debt burden (interest) and taxes, allowing objective comparison of companies.
Main source for growth
High operating profit provides resources for investments, business expansion, and increased competitiveness.

If a company shows strong operating profit, it signals to investors that the core business is operating efficiently, even if net profit is temporarily reduced due to debt or tax burden.

Annual Operating Income Aurora Cannabis

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-283 M	-491 M	-318 M	-95.8 M	-	-	-	-	-	-	-

All numbers in CAD currency

Indicator range from annual reports

Maximum	Minimum	Average
-95.8 M	-491 M	-297 M

Operating Income of other stocks in the Drug manufacturers industry

Issuer	Operating Income	Price	% 24h	Market Cap	Country
AcelRx Pharmaceuticals ACRX	-13.5 M	-	7.5 %	$ 6.35 M	USA
Aerie Pharmaceuticals AERI	-46.4 M	-	-	$ 754 M	USA
Agile Therapeutics AGRX	-19.9 M	-	10.11 %	$ 58.2 M	USA
Adamis Pharmaceuticals Corporation ADMP	-25.1 M	-	0.86 %	$ 117 M	USA
Cumberland Pharmaceuticals CPIX	-1.84 M	$ 4.06	4.1 %	$ 57.1 M	USA
Catalent CTLT	-749 M	-	-	$ 11.5 B	USA
Alimera Sciences ALIM	-1.93 M	-	-	$ 142 M	USA
Athenex ATNX	-70 M	-	-23.39 %	$ 1.76 M	USA
DURECT Corporation DRRX	-36.9 M	-	-	$ 50.1 M	USA
Eagle Pharmaceuticals EGRX	81 M	-	-39.89 %	$ 27.7 M	USA
Endo International plc ENDP	-469 M	-	-	$ 28.9 M	Irlanda
Avadel Pharmaceuticals plc AVDL	-42.4 M	-	-	$ 2.06 B	France
Evoke Pharma EVOK	-7.43 M	-	-	$ 36.6 M	USA
Calliditas Therapeutics AB (publ) CALT	-524 M	-	-0.1 %	$ 2.03 B	Schweden
HEXO Corp. HEXO	-85.5 M	-	2.45 %	$ 38.1 M	Canada
Bausch Health Companies BHC	963 M	$ 5.63	1.53 %	$ 2.05 B	Canada
Canopy Growth Corporation CGC	-117 M	$ 1.19	-2.87 %	$ 128 M	Canada
Harrow Health HROW	30.5 M	$ 39.7	2.45 %	$ 1.46 B	USA
Lannett Company LCI	-176 M	-	1.15 %	$ 7.11 M	USA
OrganiGram Holdings OGI	-91.8 M	$ 1.45	0.7 %	$ 402 M	Canada
Organogenesis Holdings ORGO	-1.28 M	$ 2.35	0.86 %	$ 309 M	USA
Evolus EOLS	-32.7 M	$ 5.3	-0.19 %	$ 342 M	USA
Sundial Growers SNDL	-132 M	$ 1.51	-1.31 %	$ 3.37 M	Canada
Emergent BioSolutions EBS	-726 M	$ 8.03	-0.74 %	$ 411 M	USA
Pacira BioSciences PCRX	-73.4 M	$ 24.51	-3.35 %	$ 1.13 B	USA
Neoleukin Therapeutics NLTX	-103 M	-	-	$ 193 M	Canada
ProPhase Labs PRPH	23.6 M	-	-	$ 5.07 M	USA
cbdMD YCBD	-3.32 M	$ 1.01	-	$ 4.36 M	USA
Radius Health RDUS	-54.3 M	-	-	$ 1.42 B	USA
Assertio Holdings ASRT	-21.5 M	$ 18.04	0.11 %	$ 116 M	USA
PetIQ PETQ	37.1 M	-	1.64 %	$ 400 M	USA
Solid Biosciences SLDB	-179 M	$ 7.92	-3.65 %	$ 693 M	USA
Relmada Therapeutics RLMD	-59.1 M	$ 7.21	-0.55 %	$ 285 M	USA
Sonoma Pharmaceuticals SNOA	-3.71 M	$ 1.14	-36.67 %	$ 1.41 M	USA
Recro Pharma REPH	-3.57 M	-	-4.76 %	$ 65.3 M	USA
Tilray TLRY	-1.37 B	$ 6.75	-2.74 %	$ 4.17 B	Canada
OptiNose OPTN	-22.7 M	-	-	$ 1.08 B	USA
SCYNEXIS SCYX	-16.1 M	$ 1.02	-2.86 %	$ 50.9 M	USA
PLx Pharma PLXP	-40.8 M	-	-27.8 %	$ 2.56 M	USA
Veru VERU	-36.9 M	$ 2.32	0.43 %	$ 313 M	USA
Viatris VTRS	766 M	$ 14.59	-1.08 %	$ 17.5 B	USA
Zomedica Corp. ZOM	-84.4 M	-	-0.21 %	$ 98 M	USA
Zynerba Pharmaceuticals ZYNE	-35.3 M	-	-	$ 55.5 M	USA
Rockwell Medical RMTI	-4.69 M	$ 0.87	1.99 %	$ 31.3 M	USA
Tricida TCDA	-153 M	-	-	$ 3.25 M	USA
China Pharma Holdings CPHI	-3.24 M	$ 0.61	1.65 %	$ 2.62 M	China
TherapeuticsMD TXMD	-4.39 M	$ 2.19	0.46 %	$ 25.3 M	USA